Table 2 Chronogram of the study
Informed Consent | □ | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Randomization | □ | |||||||||||
Exams/Visits | After Injection | |||||||||||
Baseline | pos-reperfusion | 3rd–5th day of reperfusion | 5th to 7th day | Up to 1 h | 12 h | 24 h | 6th to 9th day | 1 month | 3 months | 6 months | 1 year | |
Medical visit | □ | □ | □ | □ | □ | □ | ||||||
ALT, AST, AP, PT, aPTT and INR | □ | |||||||||||
Total Cholesterol, LDL-cholesterol, HDL-cholesterol and Triglycerides | □ | |||||||||||
Full blood panel, Glucose, Urea, Creatinine, Na+, K+, CRP | □ | □ | □ | □ | ||||||||
CK-MB mass, Troponin I | □ | □ | □ | □ | □ | |||||||
Electrocardiogram | □ | □ | □ | □ | □ | □ | □ | □ | □ | □ | ||
Echocardiogram | □ | □ | □ | □ | □ | |||||||
Cardiac MRI | □ | □ | ||||||||||
Coronary angiography | □ | □ | ||||||||||
Cells transplant | □ | |||||||||||
Cells sample storage | □ | |||||||||||
SF-36, Minnesota and Seattle QOL | □ | □ | □ | □ | ||||||||
QALY Evaluation | □ | □ | □ | |||||||||